Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study to Evaluate the Contraceptive Efficacy and Safety of Norethindrone Acetate Transdermal Delivery System

NCT01140217 is registered in ClinicalTrials.gov with Watson Pharmaceuticals as lead sponsor.

NCT NCT01140217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01140217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study to Evaluate the Contraceptive Efficacy and Safety of Norethindrone Acetate Transdermal Delivery System
Lead sponsor
Watson Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2010
Completion date
March 31, 2012
Enrollment
1,659 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

contraceptive usage